Bharat Serum IPO, this year would like to raise Rs 2000 crore by selling 30% stake through this IPO. Bharat Serum and Vaccines Limited is backed up by Kotak Private Equity Group that acquires round one fourth stake of the company. Also another company called as OrbiMed Advisor that holds 10% of the stake. This article provides the details about the Bharat Serum IPO size, Bharat Serum IPO object, background of the company, the investors and the financial performance of the company.

Stock Broker Complaints


Bharat Serum IPO Review & Ratings

Bharat Serum IPO Ratings & Review
CriteriaRatings
Industry Sentiments8.1/10
Industry Ranking8.4/10
Company Background8.0/10
Company Reputation8.0/10
Competitive Edge8.4/10
Financial Statements8.1/10
Popularity Index8.3/10
Promoters Reputation8.4/10
Retail Appetite8.1/10
Top Brokers Review8.2/10
Overall Ratings8.1/10
Star Ratings★★★★☆

Summary of Bharat Serum IPO

Bharat Serum IPOThey also develop various immunological products and kits that are used for drug delivery systems and molecular research and for the development of therapeutic products. Bharat Serum IPO to raise Rs 2000 crore by selling 30% stake through this IPO. The plant flotation may estimate round Rs 6,667 crore or it could be more, if the investors demand is higher. The company is targeting to release the IPO by mid of 2018-19. According to public forum, the company has marked the sale of around Rs 600 crore in the financial year 2015-16.
The promoters for this company may appoint investment bank Jefferies & Co. for this upcoming IPO. The lead managers of the IPO and the registrar of the IPO are yet to be disclosed. The details would be included herein shortly. The Chairman and Managing Director of the company is Mr Bharat V Daftary. The Vice Chairman and Co-Managing Director is Dr. Gautam V. Daftary. The Finance Director of the company is Mr. Nilesh R. Ganjwala.


Subscribe to Bharat Serum IPO – Fill up the Form Below

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO



    Bharat Serum IPO Date

    The Bharat Serum IPO is expected to be in market before the end of this calendar year. The company initiated the talks, so the IPO is expected to be out soon.

    Bharat Serum IPO Subscription

     Subscription
    Day 1 X
    Day 2 X
    Day 3 X
    Day 4 X
    Day 5 X

    The details of shares being subscribed would be updated on a daily basis upon release of the IPO.

    Bharat Serum IPO Allotment Status

    The details of shares allotted against the subscription would be updated once the allotment process is completed. The details would be accordingly updated.

    Bharat Serum IPO Price Band

    The price offered under the IPO is generally decided during the book building process. The IPO price has not been released yet. The details would be shortly updated in this section.

    Bharat Serum IPO Issue Size

    The Bharat Serum IPO size is expected to be close to Rs. 2000 crores. However, this is just an indicative number and the actual number would be updated once the IPO details are finalized by the Company. Please revisit us for the latest updates.

    Bharat Serum IPO Equity Share Offerings

    The number of shares being sold off by the existing investors is not disclosed yet.


    Open Free Demat Account Now!

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO


      Bharat Serum And Vaccines Limited – Company Overview

      Bharat Serum and Vaccines Limited headquarter is located in Thane but the manufacturing facilities are in Ambernath and Ahmedabad (India). The company was established in the year 1971.

      The company liaison offices are spread across different part of the world. Bharat Serum And Vaccines Limited is a Mumbai based company, ranked among the best pharma Companies and is well known for its biomedical products into 6 major divisions: Assisted Reproductive Technology, Gynecology, Nephrology & Haematology, Critical Care Emergency Medicine, Neurology and Urology.

      Bharat Serum’s main aim is to research & develop and manufacture various kinds of pharmaceutical and biomedical products that belongs to the above 6 divisions.

      They also develop various immunological products and kits that are used for drug delivery systems and molecular research and for the development of therapeutic products.

      Key members of Bharat Serum And Vaccines Limited:

      The Chairman and Managing Director of the company is Mr Bharat V Daftary.
      The Vice Chairman and Co-Managing Director is Dr. Gautam V. Daftary (M.D.)
      The Finance Director of the company is Mr. Nilesh R. Ganjwala.

      Competitive Strengths of Bharat Serum And Vaccines Limited

      Business strategy of Bharat Serum And Vaccines Limited


      Bharat Serum And Vaccines Limited – Financial Statements

      A summary of the financial position of the company is presented below:

      (The details would be updated shortly)

      Assets of the Company

      Assets (in INR & Millions)
       Mar’17Mar’16Mar’15Mar’14Mar’13
      Non-Current Asset
      Current Asset
      Total Asset

      The details would be updated shortly.

      Revenue & PAT of the Company

      Revenue & Profits (in INR & Millions)
       Mar’17Mar’16Mar’15Mar’14Mar’13
      Total Revenue
      Profit after Tax (PAT)

      Earnings per Equity Share

      Earning per Equity Share (in INR)
       Mar’17Mar’16Mar’15Mar’14Mar’13
      Basic
      Diluted

      The details would be shortly updated herein and an analysis of the same would also be presented.


      Bharat Serums And Vaccines Limited –  Promoters

      The details of the promoters would be shortly updated.

      Promoter Interest in the company.

      The details of the interest held by the promoters in the company would be updated in a few days.

      Promoter Interest in property of the company

      These details would be updated shortly.


      Bharat Serum IPO Offer Details or Issue Details

      OfferThe offer is expected to be close to Rs 1000 crores.
      Of which
      Issue reserved for the Market Makers
      Net Issue to the public
      Of which
      Allotment to retail investors
      Allotment to other investors
      Equity Shares outstanding prior to the offer
      Equity Shares outstanding after the Offer

       


      Bharat Serum IPO Issue Object

      Will be declared and updated soon.


       

      Bharat Serums IPO – Basis of the Offer Price

      The IPO offer price is determined by the company and the lead managers by market evaluation and book building process. The price is also influenced by various qualitative and quantitative factors. Some such factors are discussed below.

      The qualitative factors relevant to decide the issue price:

      • Established since long
      • Has survived a few cycles of economies
      • Collaboration with big brands

      The quantitative factors relevant for the issue price are:

      • Earning per share
      • Price/earning ratio
      • Return on Net Worth
      • Net Asset Value – NAV per Equity Share

      Bharat Serum IPO Lead Managers

      Lead Managers
      To be updated shortly

      Bharat Serum IPO Registrar to offer

      Registrar to offer
      To be updated shortly

      Bharat Serums IPO Review by Top 10 Stock Brokers

      Top Stock Brokers ReviewCompany ReputationCompetitive EdgeFinancial StatementPopularity IndexPromoters Reputation
      Angel Broking
      Sharekhan
      Kotak Securities
      ICICI Direct
      IIFL
      Edelweiss
      Zerodha
      5Paisa
      Karvy
      Motilal Oswal

      The ratings would be updated once the financials and the other details of the IPO are released.


      Bharat Serum IPO Grey Market Premium

      Grey market for Bharat Serum IPO would open 15 days before the release of the IPO.


      Subscribe to Bharat Serum IPO – Fill up the Form Below

        Fill Your Details Here
        1. Open Demat AccountInvest in IPO


        Bharat Serum IPO News

        News 1 : Bharat Serum planning to release IPO to raise Rs 2,000 crore.


        Market Guide


        Featured Topics


         

        Get 100% IPO Allotment Guarantee! Subscribe to IPO